Skip to main content
Clinical Kidney Journal logoLink to Clinical Kidney Journal
. 2014 Aug 21;7(5):493–494. doi: 10.1093/ckj/sfu088

A strange epigastric pain

Eleonora Riccio 1, Michele Santangelo 1, Alessandro Scotti 1, Antonio Pisani 1
Editor: G H Neild
PMCID: PMC4379346  PMID: 25878786

A 53-year-old woman with autosomal dominant polycystic kidney disease (ADPKD) and Stage 2 chronic kidney disease was hospitalized for early satiety, nausea, vomiting and epigastric pain.

An abdominal computed tomography scan confirmed the presence of multiple bilateral renal cysts, and a markedly enlarged liver due to the presence of multiple enormous cysts (the biggest one 20 × 16 cm) occupying most of the abdomen and compressing the stomach and other surrounding structures. The patient underwent laparoscopic cyst fenestration. The large cyst was punctured and aspirated with laparoscopic aspiration needle and subsequently deroofed by using ultrasonic dissection.

The procedure induced liver volume reduction with subsequent symptom relief.

Liver involvement is the most frequent extra-renal manifestation in ADPKD [13]. Symptoms in patients with polycystic liver are mostly absent, but they may develop because of increasing cyst size [4].

Several therapeutic options are presently available for the management of symptomatic hepatic cysts, which include aspiration–sclerotherapy, cyst fenestration, partial liver resection and liver transplantation [5].

Laparoscopic fenestration has become the standard of care for symptomatic hepatic cysts (Figure 1).

Fig. 1.

Fig. 1.

(A, B, C) CT scan of large cyst (arrowheads) arising from II to III hepatic segment (axial, coronal and sagittal sections). (D, E, F) Intra-operative laparoscopic images of cyst fenestration and omentoplasty. (D) Hepatic cysts (arrow). (E) Detail of compression of the cyst on stomach. (F) Residual cystic cavity (post-aspiration of its contents and resection of the exophytic wall) (arrow) and omentoplasty.

References

  • 1.Chaveau D, Fakhouri F, Grünfeld J. Liver involvement in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2000;11:1767–1775. doi: 10.1681/ASN.V1191767. [DOI] [PubMed] [Google Scholar]
  • 2.Everson GT. Hepatic cysts in autosomal dominant polycystic kidney disease. Mayo Clin Proc. 2007;65:1020–1025. doi: 10.1016/s0025-6196(12)65165-9. [DOI] [PubMed] [Google Scholar]
  • 3.Gabow PA, Johnson AM, Kaehny WD, et al. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology. 1990;11:1033–1037. doi: 10.1002/hep.1840110619. [DOI] [PubMed] [Google Scholar]
  • 4.Arnold HL, Harrison SA. New advances in evaluation and management of patients with polycystic liver disease. Am J Gastroenterol. 2005;100:2569–2582. doi: 10.1111/j.1572-0241.2005.00263.x. [DOI] [PubMed] [Google Scholar]
  • 5.Everson GT, Taylor MR, Doctor RB. Polycystic disease of the liver. Hepatology. 2004;40:774–782. doi: 10.1002/hep.20431. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Kidney Journal are provided here courtesy of Oxford University Press

RESOURCES